Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
43.85B | 43.55B | 37.77B | 34.54B | 33.56B | 37.49B | Gross Profit |
15.07B | 14.75B | 12.41B | 11.30B | 11.79B | 13.26B | EBIT |
2.96B | 3.64B | 2.31B | 1.78B | 2.35B | 3.75B | EBITDA |
4.21B | 4.77B | 3.48B | 2.91B | 3.37B | 4.75B | Net Income Common Stockholders |
2.29B | 2.77B | 1.63B | 1.24B | 1.62B | 2.58B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
15.33B | 17.64B | 15.58B | 15.34B | 14.12B | 12.46B | Total Assets |
44.12B | 47.45B | 44.76B | 42.14B | 41.56B | 41.35B | Total Debt |
0.00 | 204.00M | 195.00M | 0.00 | 0.00 | 0.00 | Net Debt |
-15.33B | -13.44B | -15.38B | -15.34B | -14.12B | -12.46B | Total Liabilities |
7.63B | 9.39B | 8.54B | 6.75B | 6.63B | 7.30B | Stockholders Equity |
36.48B | 38.07B | 36.22B | 35.40B | 34.93B | 34.05B |
Cash Flow | Free Cash Flow | ||||
0.00 | 3.23B | 973.00M | 1.89B | 2.15B | 2.18B | Operating Cash Flow |
0.00 | 4.27B | 1.68B | 2.87B | 3.26B | 3.36B | Investing Cash Flow |
0.00 | -1.17B | -636.00M | -1.53B | -697.00M | -2.54B | Financing Cash Flow |
0.00 | -1.06B | -810.00M | -805.00M | -804.00M | -757.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥9.90B | 8.67 | 4.61% | -4.86% | 31.21% | ||
77 Outperform | ¥27.08B | 8.34 | 6.41% | 3.16% | -3.36% | ||
76 Outperform | ¥52.57B | 16.65 | 1.70% | 9.88% | 62.68% | ||
75 Outperform | ¥39.60B | 15.37 | 3.13% | 2.45% | -2.31% | ||
66 Neutral | $4.49B | 12.22 | 5.40% | 3.71% | 4.17% | -11.97% | |
65 Neutral | ¥108.70B | 37.84 | 3.81% | 3.98% | -64.82% | ||
49 Neutral | ¥29.76B | 158.92 | ― | -11.92% | ― |